Elevated glial fibrillary acidic protein levels with a high increase rate are observed in females, especially those who are premenopausal, which suggests the potential utility of glial fibrillary acidic protein as a gender-specific biomarker for predicting dementia risk in women26. Here, GFAP is linked to dementia.